Artara Therapeutics Inc (TARA) Stock Price, Quote & News

Company Profile

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving pare...

Industry: Biotechnology

Sector: Healthcare

Phone: 646 844 0337

Website: www.protaratx.com

Address:

345 Park Avenue South, 3rd Floor, New York, United States

BeardyMcBeard Nov. 14 at 7:35 PM

Nice call @Swing_Tradr , got in $TARA earleir this week, been killing it. Nice ending a friday on a good note

0 · Reply

keokeostwiz Nov. 14 at 4:09 PM

$TARA Moving day

0 · Reply

JoeyDeNiro Nov. 14 at 6:30 AM

$TARA i currently have CABA and IRWD and just discovered this. Very similar fundamentals to those, when is the next catalyst or FDA result expected?

0 · Reply

Shawnjo44 Nov. 13 at 4:43 AM

$TARA consolidating and ready for another push

0 · Reply

keokeostwiz Nov. 12 at 3:35 PM

$TARA Low volume drip.....soon to be followed with WHAM.....uptick.....GL

0 · Reply

PiratesKingLuffy Nov. 12 at 3:07 AM

AMZE Expecting a big move here tomorrow. Very bullish close today!! AMZE has extended its partnership with Adobe Express, expanding platform access to creators in India — a market with over 2 million monetized creators and $350B in consumer spending. The integration lets users design and sell custom merchandise directly on Amaze, streamlining the path from creation to commerce. The expansion follows Amaze’s showcase at Adobe MAX 2025. Lets bank on AMZE such a gem here! $BYND $ASST $TARA $NEOV ./

1 · Reply

keokeostwiz Nov. 11 at 8:45 PM

$TARA The same hedge funds and dark pools who sank this on low volume on Friday to 4.11 .....buying back today with high volume.......retail always lose money to these shisters

0 · Reply

RealBright Nov. 11 at 8:42 PM

$TARA BlackRock didn’t stumble into NXXT. They bought 582K shares for a reason. Same with Vanguard +595K and UBS tripling up. 3M shares gone. $1.74 holding steady. ER is the fuse. This explodes soon.

1 · Reply

pablo4 Nov. 11 at 7:34 PM

$TARA gravity-defying move!

1 · Reply

Eddie5150 Nov. 11 at 7:16 PM

$TARA beautiful 👏👏👏

0 · Reply

Protara Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update

Nov 4, 2025, 4:05 PM EST - 10 days ago

Protara Therapeutics Named a 2026 Best Places to Work Winner by BioSpace

Oct 1, 2025, 4:03 PM EDT - 6 weeks ago

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 27, 2025, 8:00 AM EDT - 2 months ago

Protara Therapeutics to Participate in Upcoming Investor Conferences

Aug 11, 2025, 8:00 AM EDT - 3 months ago

Protara Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update

Jun 30, 2025, 8:00 AM EDT - 4 months ago

Protara Therapeutics Announces Addition to the Russell 3000® Index

Jun 2, 2025, 4:04 PM EDT - 5 months ago

Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer

May 8, 2025, 8:00 AM EDT - 6 months ago

Protara Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update

Apr 26, 2025, 10:00 AM EDT - 7 months ago

Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC

Apr 23, 2025, 8:00 AM EDT - 7 months ago

Protara Therapeutics to Host Conference Call and Webcast to Review Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC on Monday, April 28, 2025

Apr 15, 2025, 4:13 PM EDT - 7 months ago

Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer

Apr 10, 2025, 4:05 PM EDT - 7 months ago

Protara Therapeutics to Present Interim Analysis from the Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting

Mar 28, 2025, 5:10 PM EDT - 8 months ago

Protara Therapeutics: Speculative Buy On Promising TARA-002 Trial Results

Mar 19, 2025, 8:00 AM EDT - 8 months ago

Protara Therapeutics Announces Encore Presentation of Results from THRIVE-1 Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support

Mar 5, 2025, 8:00 AM EST - 9 months ago

Protara Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

Feb 26, 2025, 8:00 AM EST - 9 months ago

Protara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Jan 13, 2025, 8:00 AM EST - 10 months ago

Protara Highlights Recent Updates and Anticipated 2025 Milestones

Dec 14, 2024, 8:30 AM EST - 1 year ago

Protara Therapeutics: Rising From The Ashes

Dec 11, 2024, 4:05 PM EST - 1 year ago

Protara Announces Closing of $100 Million Public Offering

Dec 10, 2024, 5:00 PM EST - 1 year ago

Protara Therapeutics: Carving New Roads In Bladder Cancer

Dec 10, 2024, 3:55 PM EST - 1 year ago

Protara: Six-Month NMIBC Treatment Data Bodes Well For Mid-2025 Catalyst

Dec 9, 2024, 11:35 PM EST - 1 year ago

Protara Announces Pricing of $100 Million Public Offering

Dec 9, 2024, 4:01 PM EST - 1 year ago

Protara Announces Proposed Public Offering

Dec 5, 2024, 10:50 AM EST - 1 year ago

Why Is Protara Therapeutics Stock Skyrocketing Over 100% On Thursday?

Nov 15, 2024, 5:52 PM EST - 1 year ago

Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the 25th Annual Meeting of the Society of Urologic Oncology

Nov 6, 2024, 8:00 AM EST - 1 year ago

Protara Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference

Oct 21, 2024, 8:00 AM EDT - 1 year ago

Protara Therapeutics Granted FDA Fast Track Designation for Intravenous Choline Chloride for Patients Receiving Parenteral Support

Sep 9, 2024, 8:05 AM EDT - 1 year ago

Protara Therapeutics Announces Completion of First Cohort in Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations

Sep 9, 2024, 8:00 AM EDT - 1 year ago

Protara Therapeutics Announces Results from THRIVE-1, a Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support

Sep 3, 2024, 8:00 AM EDT - 1 year ago

Protara Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Jun 24, 2024, 5:06 PM EDT - 1 year ago

Protara Therapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

May 21, 2024, 8:00 AM EDT - 1 year ago

Protara Therapeutics to Present at the TD Cowen 5th Annual Oncology Innovation Summit

May 2, 2024, 8:00 AM EDT - 1 year ago

Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update

Apr 5, 2024, 8:04 AM EDT - 1 year ago

Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing

Apr 5, 2024, 8:02 AM EDT - 1 year ago

Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition

Apr 5, 2024, 8:00 AM EDT - 1 year ago

Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC

Mar 13, 2024, 8:00 AM EDT - 1 year ago

Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Feb 28, 2024, 8:00 AM EST - 1 year ago

Protara Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference

Feb 22, 2024, 8:55 AM EST - 1 year ago

Protara: A Bombed Out Biotech With A Very Positive Skew

CGON

Nov 30, 2023, 8:30 AM EST - 2 years ago

Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology

Nov 3, 2023, 8:00 AM EDT - 2 years ago

Protara Therapeutics Announces Third Quarter 2023 Financial Results and Business Update

Oct 23, 2023, 8:00 AM EDT - 2 years ago

Protara Therapeutics Announces Dosing of First Patient in Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations

Sep 20, 2023, 8:30 AM EDT - 2 years ago

Protara Therapeutics Announces Dosing of First Patient in Phase 1b/2 ADVANCED-2 Trial of TARA-002 in NMIBC Patients with High Grade Carcinoma in Situ

Sep 5, 2023, 7:30 AM EDT - 2 years ago

Protara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 3, 2023, 8:00 AM EDT - 2 years ago

Protara Therapeutics Announces Second Quarter 2023 Financial Results and Business Update

May 4, 2023, 8:00 AM EDT - 2 years ago

Protara Therapeutics Announces First Quarter 2023 Financial Results and Business Update

May 2, 2023, 8:00 AM EDT - 2 years ago

Protara Therapeutics Receives Regulatory Clearance from FDA to Commence Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations

Apr 28, 2023, 8:00 AM EDT - 2 years ago

Protara Therapeutics Announces Positive Preliminary Data from ADVANCED-1 Phase 1a Dose Escalation Trial of TARA-002 in NMIBC Supporting Advancement into Phase 2 Clinical Development

Mar 8, 2023, 8:00 AM EST - 2 years ago

Protara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Feb 2, 2023, 8:00 AM EST - 3 years ago

Protara Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day

BeardyMcBeard Nov. 14 at 7:35 PM

Nice call @Swing_Tradr , got in $TARA earleir this week, been killing it. Nice ending a friday on a good note

0 · Reply

keokeostwiz Nov. 14 at 4:09 PM

$TARA Moving day

0 · Reply

JoeyDeNiro Nov. 14 at 6:30 AM

$TARA i currently have CABA and IRWD and just discovered this. Very similar fundamentals to those, when is the next catalyst or FDA result expected?

0 · Reply

Shawnjo44 Nov. 13 at 4:43 AM

$TARA consolidating and ready for another push

0 · Reply

keokeostwiz Nov. 12 at 3:35 PM

$TARA Low volume drip.....soon to be followed with WHAM.....uptick.....GL

0 · Reply

PiratesKingLuffy Nov. 12 at 3:07 AM

1 · Reply

keokeostwiz Nov. 11 at 8:45 PM

$TARA The same hedge funds and dark pools who sank this on low volume on Friday to 4.11 .....buying back today with high volume.......retail always lose money to these shisters

0 · Reply

RealBright Nov. 11 at 8:42 PM

1 · Reply

pablo4 Nov. 11 at 7:34 PM

$TARA gravity-defying move!

1 · Reply

Eddie5150 Nov. 11 at 7:16 PM

$TARA beautiful 👏👏👏

0 · Reply

pablo4 Nov. 11 at 4:26 PM

$TARA this is why consolidation is so important. TARA's RSI previously during its recent big run-up was in the 70s at this 5.10 price point.....and it was in the 80s when it approached 6/share. Now, the RSI stands at 56 at the 5.10 price point. So, the recent profit-taking on the big run from the low 3s to near 6 provided for an easing of the relative strength buying factor to where the price can make another leg up before becoming overbought again. This is how it works for a stock in a genuine uptrend. JMO

0 · Reply

keokeostwiz Nov. 11 at 3:55 PM

$TARA -002 P2 results were very compelling as 72% complete response at 6 months and no safety issues.....this is tremendous progress for a tough to treat condition.....if momentum gains traction this could support a substantial price rise.....GL

0 · Reply

keokeostwiz Nov. 11 at 3:38 PM

$TARA Last Dec 5 2024 price jumped to 10.48 on 111.2 M volume.....history has a way of repeating its self......GL

0 · Reply

pablo4 Nov. 11 at 3:23 PM

$TARA when volume kicks in, we'll head for the 6s and 7s, IMO.

0 · Reply

keokeostwiz Nov. 10 at 7:34 PM

$TARA Signs of a pulse returning.....volume and share price rise.....GL

0 · Reply

keokeostwiz Nov. 10 at 3:26 PM

$TARA Price targets 21-30 among 5 analysts....non invasive bladder cancer market 3-4 billion....no available treatment.....supported with cash and test catalysts heading to 2026....room to run....niche position in bladder cancer therapy.....GL

0 · Reply

keokeostwiz Nov. 10 at 3:06 PM

$TARA Fortunate for those 4.13-4.17 last week.....expecting 7 by end of year.....if results this Q are good its off to the races........GL

0 · Reply

keokeostwiz Nov. 6 at 3:56 PM

$TARA Low volume sell off took TARA down to 50 day MA at 4.30......overall market dismal today....macro economic worries spooking investors......P2 results this quarter.....optimistic sentiment for recovery.....unpredictable volatile times.......GL

1 · Reply

keokeostwiz Nov. 5 at 5:14 PM

$TARA Added today as could not resist 4.37......a steal.....waiting for institutions to pump volume and blow TARA UP

0 · Reply

keokeostwiz Nov. 5 at 3:34 PM

$TARA Hedge funds and dark pools use these low volume sell offs to add aggressively .....volume will increase and price rises as near term catalysts on the horizon

0 · Reply

Eddie5150 Nov. 5 at 3:06 PM

$TARA bleeding out for no reason

0 · Reply

Eddie5150 Nov. 3 at 3:20 PM

$TARA what is this BS?

0 · Reply

Market Cap	203.35M
Revenue (ttm)	0.00
Net Income (ttm)	-44.60M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	425,100
Avg Vol	540,496
Day's Range	N/A - N/A
Shares Out	38.59M
Stochastic %K	96%
Beta	1.59
Analysts	Strong Sell
Price Target	$25.00